Alnylam Pharmaceuticals I... (ALNY)
241.97
5.22 (2.20%)
At close: Apr 23, 2025, 3:59 PM
240.61
-0.56%
Pre-market: Apr 24, 2025, 07:20 AM EDT
Givlaari Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 71.04M | 8.92M | +14.35% |
| Jun 30, 2024 | 62.13M | 4.07M | +7.01% |
| Mar 31, 2024 | 58.06M | -107.05M | -64.84% |
| Dec 31, 2023 | 165.1M | 110.95M | +204.91% |
| Sep 30, 2023 | 54.15M | -251.56M | -82.29% |
| Jun 30, 2023 | 305.7M | 29.38M | +10.63% |
| Mar 31, 2023 | 276.33M | 14.65M | +5.60% |
| Dec 31, 2022 | 261.68M | 29.41M | +12.66% |
| Sep 30, 2022 | 232.27M | 18.75M | +8.78% |
| Jun 30, 2022 | 213.51M | 26.64M | +14.26% |
| Mar 31, 2022 | 186.87M | -11.64M | -5.86% |
| Dec 31, 2021 | 198.51M | 31.47M | +18.84% |
| Sep 30, 2021 | 167.04M | 6.23M | +3.88% |
| Jun 30, 2021 | 160.81M | 25.04M | +18.44% |
| Mar 31, 2021 | 135.77M | 22.93M | +20.32% |
| Dec 31, 2020 | 112.84M | 13.64M | +13.75% |
| Sep 30, 2020 | 99.21M | 88.21M | +802.04% |
| Jun 30, 2020 | 11M | 5.72M | +108.53% |
| Mar 31, 2020 | 5.27M | -40.79M | -88.55% |
| Sep 30, 2019 | 46.07M | 7.83M | +20.49% |
| Jun 30, 2019 | 38.23M | 11.94M | +45.41% |
| Mar 31, 2019 | 26.29M | 14.22M | +117.73% |
| Dec 31, 2018 | 12.07M | 11.62M | +2525.00% |
| Sep 30, 2018 | 460K | n/a | n/a |